Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT03063034 Completed - Smoking Clinical Trials

CSD1602: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From Two King Size Menthol Cigarette Products

Start date: February 6, 2017
Phase: N/A
Study type: Interventional

This study will evaluate exposure to "tar" and nicotine from two menthol cigarette products and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products. Mouth-level exposure is the measurement of substance trapped in the cigarette butt after smoking the cigarette. Other purposes of this study are to: - Compare the plasma cotinine, a byproduct of your body's processing of nicotine, levels found in users after smoking each of two different cigarettes. - Find out the daily mouth-level exposure to cigarette "tar" and nicotine from smoking each of two different cigarettes in adult smokers. - Determine if certain measures of nicotine dependence change based on the type of cigarette smoked - To compare product liking and intent to use it again.

NCT ID: NCT03038542 Completed - Smoking Clinical Trials

Quit4hlth: Enhancing Tobacco and Cancer Control Through Framed Text Messages

Start date: May 2016
Phase: N/A
Study type: Interventional

This study evaluates a text messaging intervention through a smokers' quitline. Smokers will either receive 30 weeks of tailored, gain-framed text messages or 30 weeks of tailored, standard care text messages, both combined with standard quitline treatment. We hypothesize that the gain-framed text message intervention will increase cessation rates at 30 weeks as compared to standard care text messages.

NCT ID: NCT03015597 Completed - Smoking Cessation Clinical Trials

Pilot Study of Contingency Management for Smoking Cessation

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to see whether contingency management (CM) can be successfully added as an adjunct treatment to standard stop smoking services in outpatients undergoing treatment for opiate addiction. Forty tobacco smoking patients undergoing treatment for opiate addiction will be stratified to a CM intervention for either smoking abstinence or attendance at the clinic, whilst also receiving usual stop smoking services cessation treatment. The intervention will run for five weeks and participants will be followed up six months after the beginning of the study.

NCT ID: NCT03006224 Completed - Smoking Clinical Trials

The Effects of Secondary Smoking During One Lung Ventilation

Start date: December 2016
Phase: N/A
Study type: Interventional

Smoking and perhaps secondary smoking is associated with many perioperative and postoperative complications, especially respiratory events. Hypoxemia and airway damage can be associated with secondary smoking. The aim of study is to predict the incidence of hypoxemia and airway damage during one lung ventilation for lobectomy.

NCT ID: NCT02999399 Completed - Smoking Clinical Trials

Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism

Start date: December 1, 2016
Phase: Phase 1
Study type: Interventional

To determine whether glucobrassicin-rich Brussels sprouts can favorably modify the metabolism of the polycyclic aromatic hydrocarbon deuterated phenanthrene ([D10]phe) in current and former smokers

NCT ID: NCT02991781 Completed - Asthma Clinical Trials

Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation

Start date: January 2017
Phase: N/A
Study type: Interventional

This study will develop and experimentally test the efficiency of a neurofeedback training protocol vs. varenicline use for smoking cessation.

NCT ID: NCT02971137 Completed - Pain Clinical Trials

Pain and Smoking Study

PASS
Start date: December 22, 2017
Phase: N/A
Study type: Interventional

This purpose of this study is to test the telephone delivery of a cognitive behavioral intervention (CBI), for smoking cessation among Veteran smokers with chronic pain

NCT ID: NCT02968199 Completed - Smoking Clinical Trials

Building a Community-based Network to Promote Smoking Cessation

Start date: January 2006
Phase: N/A
Study type: Interventional

This study describes the development of a community-based network to promote smoking cessation among female smokers in Hong Kong.

NCT ID: NCT02952703 Completed - Smoking Clinical Trials

Disseminating and Implementing a Smoking Cessation Program for Pregnant and Postpartum Women

Start date: November 2016
Phase: N/A
Study type: Interventional

This study tests whether a smoking cessation intervention for pregnant women that extends postpartum (Striving to Quit (STQ)) can be implemented and disseminated outside of the research environment that established its effectiveness (40% maintained biochemically verified 6-month abstinence). The research aim is: Is Striving to Quit more effective in achieving postpartum smoking cessation than "First Breath," the current standard of care for pregnant women in Wisconsin who smoke? 250 women will be randomized into one of two study groups. Pregnant women in Group A (n=125) will receive the existing First Breath prenatal intervention. Those in Group B (Striving to Quit (STQ), n=125) will receive all Group A interventions, plus 1 additional prenatal home visit, 3 postpartum in-home smoking cessation counseling visits, 3 postpartum phone calls, and up to an additional $100 in gift cards. The primary outcome will be biochemically confirmed smoking cessation at 6-months postpartum.

NCT ID: NCT02949648 Completed - Smoking Clinical Trials

Electronic Cigarette Use and Quitting in Youth

Start date: September 2015
Phase: N/A
Study type: Observational

A mixed method (longitudinal, trajectory and qualitative studies) to provide comprehensive evidence on the impact of e-cigarette use on smoking and quitting among smoking youth in Hong Kong.